Paradigm Biopharmaceuticals Ltd.ASX: PAR

100% Recruitment in Synovial Fluid Biomarker Trial

Jul 1, 2022 at 2:51 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment